Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer

Clinical Cancer Research

Volumn 14, Issue 9, 2008, Pages 2870-2877

  Tang, Yang ^a   Zhu, Jinwei ^a   Chen, Ling ^c   Chen, Linyin ^b   Zhang, Sheng ^b   Lin, Jianyin ^a,c  

^a Research Center of Molecular Medicine   (China)

^b First Affiliated Hospital   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ARTICLE; CANCER INVASION; CANCER MORTALITY; CASE CONTROL STUDY; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENE OVEREXPRESSION; GENOTYPE; HAPLOTYPE; HEREDITY; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TUMOR LOCALIZATION; FEMALE; GENETICS; KAPLAN MEIER METHOD; MALE; MORTALITY; PATHOLOGY; STATISTICAL MODEL; STOMACH TUMOR;

CASE-CONTROL STUDIES; CHINA; FEMALE; GENOTYPE; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 52049101807     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-4042     Document Type: Article

References (40)

1. Deryugina El, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25:9-34.
2. Fridman R, Toth M, Chvyrkova I, Meroueh SO, Mobashery S. Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 2003;22:153-66.
3. Yu Q, Stamenkovic I, Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 2000;14:163-76.
4. Steffensen B, Wallon UM, Overall CM. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. J Biol Chem 1995;270:11555-66.
5. Crouch E, Sage H, Bornstein P. Structural basis for apparent heterogeneity of collagens in human basement membranes: type IV procollagen contains two distinct chains. Proc Natl Acad Sci U S A 1980;77:745-9.
6. Zheng H, Takahashi H, Murai Y, et al. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastrie carcinoma. Anticancer Res 2006;26:3579 83.
7. Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimaki A, Haglund C. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. J Clin Pathol 2006;59:618-23.
8. Zhang S, Li L, Lin JY, Lin H. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. World J Gastroenterol 2003;9:899-904.
9. Sier CF, Kubben FJ, Ganesh S, et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996;74:413-7.
10. Zhang B, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999;99:1788-94.
11. Matsumura S, Oue N, Nakayama H, et al. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 2005;131:19-25.
12. Przybylowska K, Kluczna A, Zadrozny M, et al. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Res Treat 2006;95:65-72.
13. Vairaktaris E, Vassiliou S, Nkenke E, et al. A metal-loproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 2008;34:450-5.
14. Sfar S, Saad H, Mosbah F, Gabbouj S, Chouchane L. TSP1 and MMP9 genetic variants in sporadic prostate cancer. Cancer Genet Cytogenet 2007;172:38-44.
15. Kimura Y, Noguchi T, Kawahara K, Kashima K, Daa T, Yokoyama S. Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression. Mod Pathol 2004;17:1328-37.
16. Noguchi T, Wirtz HC, Michaelis S, Gabbert HE, Mueller W. Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am J Clin Pathol 2001;115:828-34.
17. Sakakura C, Hagiwara A, Yasuoka R, et al. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneu-ploid formation. Br J Cancer 2001;84:824-31.
18. Nessling M, Solinas-Toldo S, Wilgenbus KK, Borchard F, Lichter P. Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 1998;23:307-16.
19. Kang JU, Kang JJ, Kwon KC, et al. Genetic alterations in primary gastric carcinomas correlated with clinico-pathological variables by array comparative genomic hybridization. J Korean Med Sci 2006;21:656-65.
20. Hidaka S, Yasutake T, Kondo M, et al. Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer. Anticancer Res 2003;23:3353-7.
21. Hu Z, Huo X, Lu D, et al. Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer. Clin Cancer Res 2005;11:5433-9.
22. Cotignola J, Reva B, Mitra N, et al. Matrix metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma. BMC Med Genet 2007;8:10.
23. Awakura Y, Ito N, Nakamura E. et al. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population. Cancer Lett 2006;241:59-63.
24. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31 -49.
25. Fenoglio-Preiser CMN, Carneiro F, Powell SM, et al. Tumours of the stomach. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumours: pathology and genetics of tumours of the digestive system. 1st Ed. Lyon: IARC Press; 2000. p. 37-67.
26. Owen D. The stomach. In: Sternberg SS, editor. Diagnostic surgical pathology. 3rd Ed. Philadelphia: Lippincott Williams and Wilkins; 1999. p. 1330-4.
27. Murray GI, Duncan ME, Arbuckle E, Melvin WT, Fothergill JE. Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 1998;43:791-7.
28. David L, Nesland JM, Holm R, Sobrinho-Simoes M. Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. An immuno-histochemical study of 87 patients. Cancer 1994;73:518-27.
29. Jakowlew SB. Transforming growth factor-β in cancer and metastasis. Cancer Metastasis Rev 2006;25:435-57.
30. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H. Transforming growth factor-β1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 1991;266:11436-41.
31. Kabashima A, Maehara Y, Kakeji Y, Baba H, Koga T, Sugimachi K. Clinicopathological features and overex-pression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res 2000;6:3581-4.
32. Zhu YQ, Zhu ZG, Liu BY, Chen XH, Yin HR, Wang XH. [Chromosomal alterations analyzed by comparative genomic hybridization in primary gastric carcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi 2007;10:160-4.
33. Nakanishi M, Sakakura C, Fujita Y, et al. Genomic alterations in primary gastric cancers analyzed by comparative genomic hybridization and clinicopathological factors. Hepatogastroenterology 2000;47:658-62.
34. Kong G, Oga A, Park CK, Kawauchi S, Furuya T, Sasaki K. DNA sequence copy number aberrations associated with histological subtypes and DNA ploidy in gastric carcinoma. Jpn J Cancer Res 2001;92:740-7.
35. Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002;2:657-72.
36. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-74.
37. Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reynolds JJ, Murphy G. Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J 1995;309:299-306.
38. Tordai H, Patthy L. The gelatin-binding site of the second type-II domain of gelatinase A/MMP-2. Eur J Biochem 1999;259:513-8.
39. Pickford AR, Potts JR, Bright JR, Phan I, Campbell ID. Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain. Structure 1997;5:359-70.
40. Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet 2001;10:591 - 7.